Primary Health Props - Director/PDMR Shareholding
Primary Health Properties PLC
("PHP" or the "Company"),
Director/PDMR Shareholding
The Company has been notified that the following information relating to the transaction detailed below has been filed with the FCA in accordance with Article 19(1) of the Market Abuse Regulation.
1
Details of person discharging managerial responsibilities/person closely associated
(a)
Name
Richard Howell
2
Reason for notification
(a)
Position/Status
Chief Financial Officer
(b)
Initial notification/amendment
Initial notification
3
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
(a)
Name
Primary Health Properties PLC
(b)
LEI
213800Y5CJHXOATK7X11
4
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
(a)
Description of the financial instrument
Ordinary shares of 12.5p
ISIN: GB00BYRJ5J14
(b)
Nature of the transaction
Grant of options under all employee share plan (ShareSave)
(c)
Price(s) and volume(s)
Price(s)
Volume(s)
£0.76
23,947
(d)
Aggregated volume
Price
23,947
£0.76
(e)
Date of transaction
29 May 2026
(f)
Place of transaction
Outside of a trading venue
For further information
Mark Davies CEO Richard Howell CFO
Primary Health Properties PLC Primary Health Properties PLC
David Purcell Investor Relations
Primary Health Properties PLC
T: +44 (0) 7921 190 136
E: david.purcell@phpgroup.co.uk
Sodali & Co Financial PR
Elly Williamson/Louisa Henry/Saskia Bottomley
T: +44 (0) 207 250 1446 E: PHP@client.sodali.com
The Company has a primary listing on the London Stock Exchange and a secondary listing on the JSE Limited.
Legal Entity Identifier: 213800Y5CJHXOATK7X11
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.ENDDSHBUGDUUGXDGLG
